“They just hugged me and told me we were going to get through this. It was really hard seeing them, especially my sister.”
By early June, Megan had begun a two-year course of immunotherapy at the Mitchell Cancer Institute, Alabama.
“There’s a 50/50 chance if it works for you or not,” she said about immunotherapy. “And if it doesn’t then it’s basically a death sentence.”
The treatment caused her tumours to “swell” in the beginning but, now, her cancerous lesions, which she still has, are not plainly visible.